Litzenburger
Achim Litzenburger, Fischbach/nahe DE
Patent application number | Description | Published |
---|---|---|
20140065031 | CONTAINER, TUBE OR CHEMICAL APPARATUS WITH COLOR INDICATOR, AND COMPOSITE SEMI-FINISHED PRODUCT WITH COLOR INDICATOR FOR PRODUCING A CONTAINER, TUBE OR CHEMICAL APPARATUS - The invention relates to a container, tube or chemical apparatus, in particular for the construction of chemical apparatus for storing or for transporting aggressive storage media, comprising a solid inner layer with the inner side of which the storage medium can come into contact and which is made of a thermoplastic that is resistant to the storage medium, comprising an adhesion-promoting layer applied to the outer side of the inner layer, which is made of a textile sheet-like structure, and comprising a carrier layer applied to the outer side of the adhesion-promoting layer for providing mechanical support to the layer structure, wherein between the inner layer and the outer layer an indicator layer is provided, the material of the indicator layer being discolored by components of the storage medium which permeate through the inner layer. | 03-06-2014 |
20140076452 | METHOD FOR PRODUCING A TUBE OR SEMI-FINISHED TUBE AND TUBE OR SEMI-FINISHED TUBE FOR CHEMICAL APPARATUS CONSTRUCTION - The invention relates to a tube ( | 03-20-2014 |
Achim K.e. Litzenburger, Fischbach/nahe DE
Patent application number | Description | Published |
---|---|---|
20140065031 | CONTAINER, TUBE OR CHEMICAL APPARATUS WITH COLOR INDICATOR, AND COMPOSITE SEMI-FINISHED PRODUCT WITH COLOR INDICATOR FOR PRODUCING A CONTAINER, TUBE OR CHEMICAL APPARATUS - The invention relates to a container, tube or chemical apparatus, in particular for the construction of chemical apparatus for storing or for transporting aggressive storage media, comprising a solid inner layer with the inner side of which the storage medium can come into contact and which is made of a thermoplastic that is resistant to the storage medium, comprising an adhesion-promoting layer applied to the outer side of the inner layer, which is made of a textile sheet-like structure, and comprising a carrier layer applied to the outer side of the adhesion-promoting layer for providing mechanical support to the layer structure, wherein between the inner layer and the outer layer an indicator layer is provided, the material of the indicator layer being discolored by components of the storage medium which permeate through the inner layer. | 03-06-2014 |
Manfred Litzenburger, Bruchsal DE
Patent application number | Description | Published |
---|---|---|
20090137214 | USER TERMINAL FOR RADIO COMMUNICATIONS, AND METHOD OF OPERATION THEREOF - A method is provided of operation of a user terminal in a network for radio communications comprising a first radio access network and a second radio access network. The user terminal comprising a first radio, a second radio, a first antenna and a second antenna. The first radio comprises two ports for connection to antennas. At least one of the two antennas is switchably connectable to each of the radios. The method comprising the following steps: connecting the two antennas to the first radio such that each port is connected to a respective antenna, and receiving data at the first radio passed via a radio communication connection from a first radio access network to the two antennas; switching the second antenna from connection to the first radio to connection to the second radio, receiving data at the first radio passed via a radio communication connection from the first radio access network to the first antenna, and receiving data at the second radio passed via a radio communication connection from a second radio access network to the second antenna. | 05-28-2009 |
Michael Litzenburger, Munchen DE
Patent application number | Description | Published |
---|---|---|
20150127092 | CATHETER SYSTEM FOR INTRODUCING AN EXPANDABLE HEART VALVE STENT INTO THE BODY OF A PATIENT, - The invention relates to catheter system for introducing an expandable heart valve stent ( | 05-07-2015 |
Tobias Litzenburger, Planegg DE
Patent application number | Description | Published |
---|---|---|
20120114659 | Antibodies for Guanylyl Cyclase Receptors - Monoclonal antibodies that act as potentiators, stimulators and agonists of guanylyl cyclase receptors are disclosed. | 05-10-2012 |
Tobias Litzenburger, Mittelbiberach DE
Patent application number | Description | Published |
---|---|---|
20110243932 | ANTI-CD40 ANTIBODIES - The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same. | 10-06-2011 |
20110311553 | Effectors of PAR-2 Activation and Their Use in the Modulation of Inflammation - The present invention relates to the recognition that PAR-2 receptors amplify the inflammatory response and that effectors of PAR-2 activation can thus be used to modulate the inflammatory response and thereby impart therapeutic benefit to patients. The invention is particularly directed to the use of PAR-2 effectors in the treatment of inflammation and nociception (pain) caused by inflammation, cancer and injury. The invention is particularly directed to negative effectors of PAR-2 activation, and more particularly to anti-PAR-2 antibodies that are negative effectors of PAR-2 activation. | 12-22-2011 |
20120027780 | ANTICOAGULANT ANTIDOTES - The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants. | 02-02-2012 |
20120276123 | ANTICOAGULANT ANTIDOTES - The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants. | 11-01-2012 |
20130011391 | ANTI-PSGL-1 ANTIBODIES AND USES THEREOF - Provided herein, in one aspect, are antibodies that immunospecifically bind to PSGL-1, polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to PSGL-1, as well as methods of treating a disorder or disease caused by or associated with increased proliferation and/or numbers of activated T cells using the antibodies described herein. | 01-10-2013 |
20130209449 | ANTI-PSGL-1 ANTIBODIES AND USES THEREOF - Provided herein, in one aspect, are antibodies that immunospecifically bind to PSGL-1, polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to PSGL-1, as well as methods of treating a disorder or disease caused by or associated with increased proliferation and/or numbers of activated T cells using the antibodies described herein. | 08-15-2013 |
20130251708 | ANTI-PSGL-1 ANTIBODIES AND USES THEREOF - Provided herein, in one aspect, are antibodies that immunospecifically bind to PSGL-1, polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to PSGL-1, as well as methods of treating a disorder or disease caused by or associated with increased proliferation and/or numbers of activated T cells using the antibodies described herein. | 09-26-2013 |
20130289248 | ANTICOAGULANT ANTIDOTES - The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants. | 10-31-2013 |
20140179907 | ANTI-CD40 ANTIBODIES - The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same. | 06-26-2014 |
20140377265 | ANTICOAGULANT ANTIDOTES - The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants. | 12-25-2014 |
20150118225 | ANTICOAGULANT ANTIDOTES - The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants. | 04-30-2015 |
Tobias Litzenburger, Newtown, CT US
Patent application number | Description | Published |
---|---|---|
20100119506 | Effectors of PAR-2 Activation and Their Use in the Modulation of Inflammation - The present invention relates to the recognition that PAR-2 receptors amplify the inflammatory response and that effectors of PAR-2 activation can thus be used to modulate the inflammatory response and thereby impart therapeutic benefit to patients. The invention is particularly directed to the use of PAR-2 effectors in the treatment of inflammation and nociception (pain) caused by inflammation, cancer and injury. The invention is particularly directed to negative effectors of PAR-2 activation, and more particularly to anti-PAR-2 antibodies that are negative effectors of PAR-2 activation. | 05-13-2010 |
Ulricke Litzenburger, Dossenheim DE
Patent application number | Description | Published |
---|---|---|
20140294860 | MEANS AND METHODS FOR TREATING AND/OR PREVENTING NATURAL AHR LIGAND-DEPENDENT CANCER - The present invention relates to the field of cancer therapeutics and treatment of cancer. In particular, it relates to a method for treating and/or preventing a natural AHR ligand-dependent cancer comprising administering to a subject suffering from said cancer a therapeutically effective amount of an AHR inhibitor. Moreover, contemplated is a AHR inhibitor for use in treating and/or preventing a natural AHR ligand-dependent cancer. | 10-02-2014 |